Journal Information

Statistics

Follow this link to access the full text of the article

Caso Clínico
Melanoma tipo lentigo maligno extenso no couro cabeludo tratado com Imiquimod 5% e 3,75%
Miriam Rovesti
Corresponding author
miriam.rovesti@gmail.com

Autor para correspondência.
, Alfredo Zucchi, Claudio Feliciani, Francesca Satolli
Departamento de Dermatologia, University of Parma, Parma, Itália
Read
7975
Times
was read the article
2211
Total PDF
5764
Total HTML
Share statistics
Article information
ISSN: 26662752
Original language: Portuguese
The statistics are updated each day
Year/Month Html Pdf Total
2024 May 76 30 106
2024 April 198 100 298
2024 March 198 85 283
2024 February 262 98 360
2024 January 210 80 290
2023 December 176 66 242
2023 November 240 82 322
2023 October 226 76 302
2023 September 234 79 313
2023 August 227 54 281
2023 July 243 57 300
2023 June 221 55 276
2023 May 234 33 267
2023 April 238 27 265
2023 March 225 46 271
2023 February 218 30 248
2023 January 169 51 220
2022 December 132 29 161
2022 November 186 53 239
2022 October 177 52 229
2022 September 138 79 217
2022 August 161 59 220
2022 July 154 67 221
2022 June 149 52 201
2022 May 139 66 205
2022 April 155 64 219
2022 March 113 73 186
2022 February 111 51 162
2022 January 147 112 259
2021 December 87 88 175
2021 November 86 74 160
2021 October 149 142 291
2021 September 62 76 138
2021 August 23 25 48
Show all

Follow this link to access the full text of the article

Idiomas
Anais Brasileiros de Dermatologia
en pt
Cookies policy Política de cookies
To improve our services and products, we use "cookies" (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here. Utilizamos cookies próprios e de terceiros para melhorar nossos serviços e mostrar publicidade relacionada às suas preferências, analisando seus hábitos de navegação. Se continuar a navegar, consideramos que aceita o seu uso. Você pode alterar a configuração ou obter mais informações aqui.